Angiotensin II-Independent Upregulation of Cyclooxygenase-2 by Activation of the (Pro) Renin Receptor in Rat Renal Inner Medullary Cells

被引:59
|
作者
Gonzalez, Alexis A. [2 ]
Luffman, Christina
Bourgeois, Camille R. T.
Vio, Carlos P. [3 ]
Prieto, Minolfa C. [1 ,2 ,4 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Physiol, Sch Med, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Renal & Hypertens Ctr Excellence, New Orleans, LA 70112 USA
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Tulane Univ, Tulane BIRCWH Program, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
cyclooxygenase-2; (pro)renin receptor; collecting duct; MAPK; ERK1/2; RENOMEDULLARY INTERSTITIAL-CELLS; COLLECTING DUCT RENIN; HUMAN MESANGIAL CELLS; THICK ASCENDING LIMB; VACUOLAR H+-ATPASE; (PRO)RENIN RECEPTOR; HYPERTENSIVE-RATS; TRANSGENIC RATS; PRORENIN RECEPTOR; COX-2; EXPRESSION;
D O I
10.1161/HYPERTENSIONAHA.112.196303
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
During renin-angiotensin system activation, cyclooxygenase-2 (COX-2)-derived prostaglandins attenuate the pressor and antinatriuretic effects of angiotensin II (AngII) in the renal medulla. The (pro)renin receptor (PRR) is abundantly expressed in the collecting ducts (CD) and its expression is augmented by AngII. PRR overexpression upregulates COX-2 via mitogen-activated kinases/extracellular regulated kinases 1/2 in renal tissues; however, it is not clear whether this effect occurs independently or in concert with AngII type 1 receptor (AT(1)R) activation. We hypothesized that PRR activation stimulates COX-2 expression independently of AT(1)R in primary cultures of rat renal inner medullary cells. The use of different cell-specific immunomarkers (aquaporin-2 for principal cells, anion exchanger type 1 for intercalated type-A cells, and tenascin C for interstitial cells) and costaining for AT(1)R, COX-2, and PRR revealed that PRR and COX-2 were colocalized in intercalated and interstitial cells whereas principal cells did not express PRR or COX-2. In normal rat kidney sections, PRR and COX-2 were colocalized in intercalated and interstitial cells. In rat renal inner medullary cultured cells, treatment with AngII (100 nmol/L) increased COX-2 expression via AT(1)R. In addition, AngII and rat recombinant prorenin (100 nmol/L) treatments increased extracellular regulated kinases 1/2 phosphorylation, independently. Importantly, rat recombinant prorenin upregulated COX-2 expression in the presence of AT(1)R blockade. Inhibition of mitogen-activated kinases/extracellular regulated kinases 1/2 suppressed COX-2 upregulation mediated by either AngII or rat recombinant prorenin. Furthermore, PRR knockdown using PRR-short hairpin RNA blunted the rat recombinant prorenin-mediated upregulation of COX-2. These results indicate that COX-2 expression is upregulated by activation of either PRR or AT(1)R via mitogen-activated kinases/extracellular regulated kinases 1/2 in rat renal inner medullary cells. (Hypertension. 2013;61:443-449.) circle Online Data Supplement
引用
收藏
页码:443 / +
页数:16
相关论文
共 50 条
  • [31] Down-regulation of Cyclooxygenase-2 by the Carboxyl Tail of the Angiotensin II Type 1 Receptor
    Sood, Rapita
    Minzel, Waleed
    Rimon, Gilad
    Tal, Sharon
    Barki-Harrington, Liza
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (45) : 31473 - 31479
  • [32] Angiotensin II Activates the Calcineurin/NFAT Signaling Pathway and Induces Cyclooxygenase-2 Expression in Rat Endometrial Stromal Cells
    Abraham, Florencia
    Sacerdoti, Flavia
    De Leon, Romina
    Gentile, Teresa
    Canellada, Andrea
    PLOS ONE, 2012, 7 (05):
  • [33] Leukotrienes, But Not Angiotensin II, Are Involved in the Renal Effects Elicited by the Prolonged Cyclooxygenase-2 Inhibition When Sodium Intake Is Low
    Salazar, Francisco
    Javier Salazar, F.
    Saez, Fara
    Reverte, Virginia
    Zweifel, Ben
    Dufield, Dawn
    Radabaugh, Melissa
    Graneto, Matt
    Llinas, Maria T.
    Masferrer, Jaime L.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 61 (04) : 329 - 336
  • [34] Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells
    Tani, Tatsuo
    Ayuzawa, Rie
    Takagi, Tetsuo
    Kanehira, Tsutomu
    Maurya, Dharmendra Kumar
    Tamura, Masaaki
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 315 (1-2) : 185 - 193
  • [35] Angiotensin II induces cyclooxygenase 2 expression in rat astrocytes via the angiotensin type 1 receptor
    O'Connor, Ann Tenneil
    Clark, Michelle A.
    NEUROPEPTIDES, 2019, 77
  • [36] Rottlerin induces cyclooxygenase-2 upregulation through an ATF4 and reactive oxygen species-independent pathway in HEI-OC1 cells
    Woo, Seon Min
    Lee, Woo Keun
    Min, Kyoung-Jin
    Kim, Dong Eun
    Park, Soon Hyung
    Nam, Sung Il
    Kwon, Taeg Kyu
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 845 - 850
  • [37] Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells
    Tatsuo Tani
    Rie Ayuzawa
    Tetsuo Takagi
    Tsutomu Kanehira
    Dharmendra Kumar Maurya
    Masaaki Tamura
    Molecular and Cellular Biochemistry, 2008, 315 : 185 - 193
  • [38] Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2
    Allison, Sarah E.
    Petrovic, Nenad
    Mackenzie, Peter I.
    Murray, Michael
    BIOCHEMICAL PHARMACOLOGY, 2015, 96 (04) : 306 - 314
  • [39] (Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells
    Gonzalez, Alexis A.
    Zamora, Leonardo
    Reyes-Martinez, Cristian
    Salinas-Parra, Nicolas
    Roldan, Nicole
    Cuevas, Catherina A.
    Figueroa, Stefanny
    Gonzalez-Vergara, Alex
    Prieto, Minolfa C.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (11): : 1134 - 1144
  • [40] Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells
    Casali, Cecilia I.
    Weber, Karen
    Faggionato, Daniela
    Morel Gomez, Emanuel
    Fernandez Tome, Maria C.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (04) : 432 - 439